All posts

Tesla’s Q2 was better than expected, this analyst says

In a July 24 report, Roth Capital Markets analyst Craig Irwin reiterated a “Buy” rating on Tesla (Tesla Stock Quote, Chart, News, Analysts, Financials NASDAQ:TSLA) and maintained a $395 price target, citing better-than-expected second-quarter results and steady progress on vehicle and robotics programs. He said the 15.0% non-GAAP auto gross margin, which beat consensus by 140 basis points, was a key highlight.

Tesla reported Q2 2025 revenue of $22.5-billion and adjusted EPS of $0.40, roughly in line with consensus but slightly below Roth’s estimates of $23.6-billion and $0.41. Non-GAAP auto gross margins came in strong at 15.0%, ahead of Roth’s 11.8% and consensus at 13.6%. Regulatory credits added $439-million, contributing about $0.12 to pre-tax EPS. A $284-million bitcoin gain also boosted results, while $300-million in tariffs, split between auto and energy, had only a modest impact but are expected to worsen in the second half.

“Guide unchanged with limited detail, other than Tesla could transition through a few rough quarters,” Irwin said. “Management cited impacts from shifting trade and fiscal policies as elevating uncertainty for 2025 deliveries. We believe volumes from the new China Model Y L and initial low-cost vehicle volumes could support upside versus consensus expectations, and we will monitor closely.”

Irwin said Tesla’s messaging around AI dominance, robotics, and vehicle expansion supports its long-term positioning. Optimus v3 is expected to begin ramping in 2026, with 1 million units targeted within five years. Q2 adjusted auto margins rose to 15.0%, boosted by new Model Y pricing, despite tariff headwinds. Tesla is progressing on new vehicle launches, including a low-cost model, a new Model Y for North America and India, and reaffirmed 2026 launches for the Cybercab and Semi.

“We reiterate our $395 target using a 12.5x revenue multiple on 2026 Estimates,” he said. “Tesla is a large-cap company that often trades like an emerging growth company. Catalysts will play a primary role in valuation, in our opinion, as investors discount the longer-term served opportunity and projected earnings power. We see abundant positive catalysts, and we would be buyers on any weakness.”

-30-

Tagged with: tsla
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Is Canada’s housing market finally on the upswing?

RBC economists say housing activity in Canada is beginning to pick up after months of recession fears and trade-related uncertainty,… [Read More]

1 day ago

Alphabet wins price target raise at Roth Capital

Roth Capital Markets analyst Rohit Kulkarni maintained a “Buy” rating on Alphabet (Alphabet Stock Quote, Chart, News, Analysts, Financials NYSE:GOOGL)… [Read More]

2 days ago

Will pot stocks ever recover?

In a July 23 report, Haywood Capital Markets analyst Neal Gilmer said he is revising estimates downward after a flat… [Read More]

2 days ago

Roth launches coverage of nVent Electric with a “Buy” rating

Roth Capital Markets has initiated coverage of nVent Electric (nVent Electric Stock Quote, Chart, News, Analysts, Financials NYSE:NVT) with a… [Read More]

2 days ago

Electromed stock is a buy, this analyst says

Roth Capital Markets has initiated coverage of Electromed (Electromed Stock Quote, Chart, News, Analysts, Financials NYSE:ELMD) with a “Buy” rating… [Read More]

2 days ago

NervGen Pharma is a buy, Research Capital says

NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials TSXV:NGEN) has appointed board chair Dr. Adam Rogers as interim… [Read More]

3 days ago